PHOENIX (AP) — A former senior executive with a Chandler-based opioid manufacturer will pay $9.5 million to settle a consumer fraud suit.
Witness: Drug company hired ex-stripper to increase sales
BOSTON (AP) — A former exotic dancer was hired as a regional sales manager at a drug company despite her lack of pharmaceutical experience because executives believed she could help carry out the...
Opioid maker used rap video to push powerful painkiller
BOSTON (AP) — Employees at a drug company accused of bribing doctors rapped and danced around a person dressed as a bottle of the highly addictive fentanyl spray in a video meant to motivate sales reps to push the drug.
Prosecutor: Drug founder driven by greed in bribing doctors
BOSTON (AP) — The wealthy founder of a drug company plotted to bribe doctors across the country to prescribe a highly addictive fentanyl spray in order to outshine competitors and line his own pockets, a federal prosecutor told jurors Monday.
Assistant U.S. Attorney David Lazarus said John Kapoor was so determined to make Insys Therapeutics Inc. a success that he turned it into a "criminal enterprise" to get the powerful painkiller in the hands of more patients.
Families hoping for justice from prescription bribes trial
BOSTON (AP) — Drug company executives weren't satisfied with sales for their powerful painkiller, so they devised a plan, prosecutors say: Offer cash to doctors in exchange for prescriptions. Soon, the highly addictive fentanyl spray was flourishing, and executives were raking in millions.
Now, the company's wealthy founder is heading to trial in a case that's putting a spotlight on the federal government's efforts to go after those it says are responsible for fueling the deadly drug crisis.
Insys Therapeutics: 3Q Earnings Snapshot
CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Monday reported a loss of $30.6 million in its third quarter.
On a per-share basis, the Chandler, Arizona-based company said it had a loss of 41 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 37 cents per share.
The specialty pharmaceutical company posted revenue of $18.3 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $22.6 million.
Insys Therapeutics: 2Q Earnings Snapshot
CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Wednesday reported a loss of $27.4 million in its second quarter.
The Chandler, Arizona-based company said it had a loss of 37 cents per share. Losses, adjusted for stock option expense, were 33 cents per share.
The specialty pharmaceutical company posted revenue of $23.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $25.4 million.
5 doctors charged with taking kickbacks to tout painkiller
NEW YORK (AP) — Five New York City doctors were arrested Friday on charges that they accepted bribes and kickbacks from an Arizona-based pharmaceutical company to prescribe large volumes of a highly addictive painkiller.
They pleaded not guilty in Manhattan federal court to an unsealed indictment charging them with conspiracy, among other charges.
PROVIDENCE, R.I. (AP) — A Rhode Island couple has filed suit over a drug company's alleged kickback scheme encouraging doctors to push a highly addictive opioid spray.
The Providence Journal reports that Woonsocket residents Lisa and Angelo Mencucci are suing Arizona-based Insys Therapeutics Inc. and Jerrold Rosenberg, a North Providence doctor.
Founder charged in opioid scheme can remove GPS monitoring
BOSTON (AP) — The founder of a pharmaceutical company charged with leading a nationwide conspiracy to bribe doctors to prescribe an opioid pain medication has won his bid to remove his electronic monitoring bracelet.
U.S. Magistrate Judge Jennifer Boal in Boston said Monday that prosecutors have shown no evidence that John Kapoor of Arizona-based Insys Therapeutics Inc. intends to flee. Prosecutors said at a hearing this month he should remain on GPS monitoring because he's a flight risk.
Drug firm founder pleads not guilty to opioid bribe scheme
BOSTON (AP) — A pharmaceutical company founder accused of leading a conspiracy to bribe doctors to prescribe a powerful opioid pain medication will fight the charges against him and believes he will be vindicated, his attorney said Thursday.
Volunteers to raise awareness about opioid abuse
TRENTON, N.J. (AP) — Some 2,000 volunteers across New Jersey are fanning out to raise awareness about opioid abuse.
Friday is Knock Out Opioid Abuse Day.
The Partnership for a Drug-Free New Jersey and other community groups are distributing information about the risks of prescription pain medications and their links to heroin abuse.
New Jersey sues painkiller company, calls its conduct ‘evil’
TRENTON, N.J. (AP) — A drug company that makes a powerful fentanyl painkiller spray has engaged in conduct that is "nothing short of evil," New Jersey's attorney general said Thursday after the state became the latest to file a lawsuit against the firm.
The suit alleges that Insys Therapeutics Inc. directed its sales force to have doctors prescribe the drug Subsys for any type of chronic pain even though it was only approved for cancer patients who couldn't benefit from other opioids.
The Latest: Massachusetts settles with fentanyl company
BOSTON (AP) — The Latest on lawsuits against Insys Therapeutics Inc. (all times local):
Massachusetts has announced a $500,000 settlement with a Phoenix-based drug company it says schemed to push sales of a powerful painkiller spray.
Attorney General Maura Healey announced the settlement Thursday against Insys Therapeutics Inc.
Healey says the company marketed the product for a variety of pain patients even though it's only approved for use in cancer patients.
AG Madigan reaches $4.5M settlement in opioid marketing case
CHICAGO (AP) — Illinois Attorney General Lisa Madigan has reached a $4.5 million settlement with an Arizona-based pharmaceutical company that her office sued for deceptive marketing of an opioid drug meant for cancer patients.
Madigan said Friday Insys Therapeutics Inc. "pushed a highly addictive opioid in complete disregard for patients' health to increase company profits."
Illinois attorney general sues drug company over marketing
CHICAGO (AP) — Illinois Attorney General Lisa Madigan has filed a lawsuit against a Phoenix-based pharmaceutical company for alleged deceptive marketing of an opioid drug meant for cancer patients.
The lawsuit filed Thursday claims Insys Therapeutics Inc. marketed its sublingual fentanyl spray Subsys to doctors who prescribed large amounts of painkillers instead of to cancer doctors.